SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
Giustina Ferone, Ji-Ying Song, Kate D Sutherland, Rajith Bhaskaran, Kim Monkhorst, Jan-Paul Lambooij, Natalie Proost, Gaetano Gargiulo, Anton Berns
Cancer Cell | CELL PRESS | Published : 2016
Awarded by National Health and Medical Research Council of Australia Overseas based Biomedical Training Fellowship
Awarded by Worldwide Cancer Research grant
Awarded by Worldwide Cancer Research
We wish to thank members of the animal facility of the Netherlands Cancer Institute for maintaining the mice; the Animal Pathology department for producing high-quality histopathological preparations; the NKI-AVL core facility Molecular Pathology & Biobanking for supplying NKI-AVL Biobank material and laboratory support; Ivo Huijbers and Colin Pritchard for assisting in generating the mutant ESC lines; and Sarah Best for experiments that were not included in the final manuscript. We wish to thank Paul Krimpenfort for his input during this work and critically reading the manuscript. This study was supported by a WKO grant to A.B. by the Dutch Cancer Society and by a Synergy ERC grant (COMBATCANCER) in which A.B. is one of the principal investigators. K.D.S. is a recipient of a National Health and Medical Research Council of Australia Overseas based Biomedical Training Fellowship (No. 516781). This work also was made possible through Victorian State Government Operational Infrastructure Support and Australian Government IRIISS, and Worldwide Cancer Research grant 14-0433.